While CARD11 mutations, which lead to a constitutively activated NFκB pathway, were demonstrated to drive diffuse large B-cell lymphoma (DLBCL) pathogenesis [50], the role in sinonasal carcinoma is unclear. This evidence concerns the gene NFKB1 and nasal cavity and paranasal sinus carcinoma.